share_log

Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $22

Benzinga ·  Nov 23, 2023 01:52

Piper Sandler analyst David Amsellem maintains Organon (NYSE:OGN) with a Overweight and lowers the price target from $32 to $22.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment